These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists. Liu KG; Robichaud AJ; Bernotas RC; Yan Y; Lo JR; Zhang MY; Hughes ZA; Huselton C; Zhang GM; Zhang JY; Kowal DM; Smith DL; Schechter LE; Comery TA J Med Chem; 2010 Nov; 53(21):7639-46. PubMed ID: 20932009 [TBL] [Abstract][Full Text] [Related]
27. Alkynyl-coumarinyl ethers as MAO-B inhibitors. Mertens MD; Hinz S; Müller CE; Gütschow M Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738 [TBL] [Abstract][Full Text] [Related]
28. Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B. Kuder KJ; Załuski M; Schabikowski J; Latacz G; Olejarz-Maciej A; Jaśko P; Doroz-Płonka A; Brockmann A; Müller CE; Kieć-Kononowicz K ChemMedChem; 2020 May; 15(9):772-786. PubMed ID: 32162782 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site. Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902 [TBL] [Abstract][Full Text] [Related]
30. An exit beyond the pharmacophore model for 5-HT Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease. Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998 [TBL] [Abstract][Full Text] [Related]
32. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease. Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824 [TBL] [Abstract][Full Text] [Related]
34. AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease. Ivachtchenko AV; Lavrovsky Y; Ivanenkov YA Mol Pharm; 2016 Mar; 13(3):945-63. PubMed ID: 26886442 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer's disease. Liu W; Lang M; Youdim MBH; Amit T; Sun Y; Zhang Z; Wang Y; Weinreb O Neuropharmacology; 2016 Oct; 109():376-385. PubMed ID: 27318273 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents. Kumar B; Kumar M; Dwivedi AR; Kumar V ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and identification of a novel derivative of salidroside as a selective, competitive inhibitor of monoamine oxidase B with enhanced neuroprotective properties. Yang Z; Huang X; Lai W; Tang Y; Liu J; Wang Y; Chu K; Brown J; Hong G Eur J Med Chem; 2021 Jan; 209():112935. PubMed ID: 33097301 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
39. SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization. Nirogi R; Abraham R; Benade V; Medapati RB; Jayarajan P; Bhyrapuneni G; Muddana N; Mekala VR; Subramanian R; Shinde A; Kambhampati R; Jasti V Behav Pharmacol; 2019 Feb; 30(1):16-35. PubMed ID: 29847336 [TBL] [Abstract][Full Text] [Related]
40. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents. Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]